Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Delayed short-term administration of granulocyte colony-stimulating factor is a good mobilization strategy for harvesting autologous peripheral blood stem cells in pediatric patients with solid tumors.

Takahashi H, Kato M, Kikuchi A, Hanada R, Koh K.

Pediatr Transplant. 2013 Nov;17(7):688-93. doi: 10.1111/petr.12137. Epub 2013 Aug 21.

PMID:
23962050
2.

Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.

Watanabe H, Watanabe T, Suzuya H, Wakata Y, Kaneko M, Onishi T, Okamoto Y, Abe T, Kawano Y, Kagami S, Takaue Y.

Bone Marrow Transplant. 2006 Apr;37(7):661-8.

PMID:
16489358
3.

Mobilization and harvesting of peripheral blood stem cells in pediatric patients with solid tumors.

Veljkovic D, Vujic D, Nonkovic OS, Jevtic D, Zecevic Z, Lazic E.

Ther Apher Dial. 2011 Dec;15(6):579-86. doi: 10.1111/j.1744-9987.2011.00990.x.

PMID:
22107695
5.

Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. The Japanese Cooperative Study Group of PBSCT.

Kawano Y, Takaue Y, Mimaya J, Horikoshi Y, Watanabe T, Abe T, Shimizu Y, Matsushita T, Kikuta A, Watanabe A, Iwai A, Ito E, Endo M, Kodani N, Ohta S, Gushi K, Azuma H, Etoh T, Okamoto Y, Amano K, Hattori H, Eguchi H, Kuroda Y.

Blood. 1998 Dec 1;92(11):4040-6.

7.

Biosimilar granulocyte-colony-stimulating factor for mobilization of autologous peripheral blood stem cells in pediatric hematology-oncology patients.

Cesaro S, Tridello G, Prete A, Dallorso S, Cannata E, Massaccesi E, Risso M, De Bortoli M, Caselli D.

Transfusion. 2015 Feb;55(2):246-52. doi: 10.1111/trf.12789. Epub 2014 Jul 29.

PMID:
25070657
8.

Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.

Nademanee AP, DiPersio JF, Maziarz RT, Stadtmauer EA, Micallef IN, Stiff PJ, Hsu FJ, Bridger G, Bolwell BJ.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1564-72. doi: 10.1016/j.bbmt.2012.05.017. Epub 2012 Jun 6.

9.

Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma.

Lefrere F, Makke J, Fermand J, Marolleau J, Dal Cortivo L, Alberti C, Mouton V, Benbunan M, Miclea J.

Bone Marrow Transplant. 1999 Sep;24(5):463-6.

10.

CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.

Todisco E, Castagna L, Sarina B, Mazza R, Magagnoli M, Balzarotti M, Nozza A, Siracusano L, Timofeeva I, Anastasia A, Demarco M, Santoro A.

Eur J Haematol. 2007 Feb;78(2):111-6.

PMID:
17313558
12.

[Peripheral blood stem cell collection in pediatric malignancies: comparison between three mobilizing regimens].

De Pasquale MD, Cacchione A, Foco M, Gozzer M, Libera F, Soscia F, Ragni G, Cappelli C.

Clin Ter. 2003 Sep-Oct;154(5):305-9. Italian.

PMID:
14994920
13.

Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer.

Somlo G, Sniecinski I, Odom-Maryon T, Nowicki B, Chow W, Hamasaki V, Leong L, Margolin K, Morgan R Jr, Raschko J, Shibata S, Tetef M, Molina A, Berenson RJ, Forman SJ, Doroshow JH.

Blood. 1997 Mar 1;89(5):1521-8.

15.

Feasibility study of IL-11 and granulocyte colony-stimulating factor after myelosuppressive chemotherapy to mobilize peripheral blood stem cells from heavily pretreated patients.

Goldman SC, Bracho F, Davenport V, Slack R, Areman E, Shen V, Lenarsky C, Weinthal J, Hughes R, Cairo MS.

J Pediatr Hematol Oncol. 2001 Jun-Jul;23(5):300-5.

PMID:
11464987
16.

Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.

Wang S, Nademanee A, Qian D, Dagis A, Park HS, Fridey J, Smith E, Snyder D, Somlo G, Stein A, Rosenthal J, Falk P, Kogut N, Palmer J, Gaal K, Kim Y, Bhatia R, Yuan S, Kay C, Weiss L, Forman S.

Transfusion. 2007 Dec;47(12):2207-16. Epub 2007 Aug 21.

PMID:
17714420
17.

Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF.

Fraipont V, Sautois B, Baudoux E, Pereira M, Fassotte MF, Hermanne JP, Jérusalem G, Longrée L, Schaaf-Lafontaine N, Fillet G, Beguin Y.

Transfusion. 2000 Mar;40(3):339-47.

PMID:
10738037
18.

The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .

Haas R, Murea S.

Cytokines Mol Ther. 1995 Dec;1(4):249-70. Review. Erratum in: Cytokines Mol Ther 1996 Mar;2(1):136.

PMID:
9384679
19.

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.

Burns LJ, Weisdorf DJ, DeFor TE, Repka TL, Ogle KM, Hummer C, Miller JS.

Exp Hematol. 2000 Jan;28(1):96-103. Erratum in: Exp Hematol. 2000 Mar;28(3):347.

PMID:
10658681
20.

Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.

Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.

Bone Marrow Transplant. 1998 Oct;22(7):625-30.

Supplemental Content

Support Center